Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations (Unaudited)

v3.23.3
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development $ 902,977 $ 1,553,295 $ 2,934,541 $ 4,761,686
General and administrative 909,001 892,777 2,887,533 3,201,111
Total operating expenses 1,811,978 2,446,072 5,822,074 7,962,797
Loss from operations (1,811,978) (2,446,072) (5,822,074) (7,962,797)
Other income and expenses:        
Interest income, net 92,767 21,486 161,357 21,486
Net loss $ (1,719,211) $ (2,424,586) $ (5,660,717) $ (7,941,311)
Net loss per share of common stock, basic and diluted $ (0.54) $ (3.16) $ (2.46) $ (11.96)
Weighted-average basic and diluted shares 3,189,034 767,275 2,301,360 663,892